Laboratorios Farmacéuticos ROVI S.A.
ROVI.MCIBEX 35
58,55 €
Dividend yield1,60 %
Continuity18 yr
Dividend0,94 €
DiviScore
ExcellentPerformance35/35
Dividend Quality30/35
AGM Date
—Ex-Date
14.07.2025Payment
—CAGR 3Y
+10.0%CAGR 5Y
-0.3%CAGR 10Y
+16.3%€10,000 invested in 2016 · with dividend reinvestment
End Value
51.411,90 €
Total Return
+414.1%
Annual Return
17.8% p.a.
Dividends Received
4.342,42 €
Dividend history
About Laboratorios Farmacéuticos ROVI S.A.
Laboratorios ROVI, based in Madrid, is a Spanish pharmaceutical company with two main strands: its own specialty medicines, led by long-acting injectable treatments, and a large contract-manufacturing business that fills and finishes drugs and vaccines for other companies. That combination gives it both proprietary products and steady manufacturing income. ROVI has paid and grown its dividend for years, funded by rising profits, though the yield is modest as it reinvests to expand. Dependable dividend growth from a well-run specialty-pharma and manufacturing business earns it a high DiviScore, with income secondary to growth.
Frequently Asked Questions
The next payment date is not yet announced.
Laboratorios Farmacéuticos ROVI S.A. has a DiviScore of 86/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Laboratorios Farmacéuticos ROVI S.A.'s current dividend yield is 1.60% based on the latest dividend.
Laboratorios Farmacéuticos ROVI S.A. (ROVI.MC) is a member of IBEX 35. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.